欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/5021/007
药品名称Crusia 2.000 IE (20 mg)/0,2 ml Injektionslösung in einer Fertigspritze
活性成分
    • Enoxaparin sodium 2.0 IU/ml
剂型Solution for injection in prefilled syringe
上市许可持有人Laboratorios Farmaceuticos Rovi, S.A. C/Julian Camarillo, 35 E-28037 Madrid Spain
参考成员国 - 产品名称Germany (DE)
Crusia 20 mg (2,000 IU/0,2 ml) solution for injection in pre-filled syringe
互认成员国 - 产品名称
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
    • Poland (PL)
许可日期2017/02/24
最近更新日期2025/02/07
药物ATC编码
    • B01AB05 enoxaparin
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Similar biological Art 10.4 Dir 2001/83/EC
  • TypeLevel4:Biological: Other
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase